These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22004878)
1. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Dréno B; Khammari A; Brocard A; Moyse D; Blouin E; Guillet G; Léonard F; Knol AC Arch Dermatol; 2012 Feb; 148(2):182-6. PubMed ID: 22004878 [TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. Mozeika E; Pilmane M; Nürnberg BM; Jemec GB Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596 [TBL] [Abstract][Full Text] [Related]
3. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464 [TBL] [Abstract][Full Text] [Related]
4. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity. Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673 [TBL] [Abstract][Full Text] [Related]
5. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566 [TBL] [Abstract][Full Text] [Related]
6. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960 [TBL] [Abstract][Full Text] [Related]
7. Verneuil's disease, innate immunity and vitamin D: a pilot study. Guillet A; Brocard A; Bach Ngohou K; Graveline N; Leloup AG; Ali D; Nguyen JM; Loirat MJ; Chevalier C; Khammari A; Dreno B J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1347-53. PubMed ID: 25512084 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467 [TBL] [Abstract][Full Text] [Related]
9. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668 [TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173 [TBL] [Abstract][Full Text] [Related]
11. Bacteriology of hidradenitis suppurativa/acne inversa: A review. Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608 [TBL] [Abstract][Full Text] [Related]
12. Human β-defensin-2 and psoriasin, two new innate immunity targets of zinc gluconate. Poiraud C; Quereux G; Knol AC; Zuliani T; Allix R; Khammari A; Dreno B Eur J Dermatol; 2012; 22(5):634-9. PubMed ID: 22854010 [TBL] [Abstract][Full Text] [Related]
13. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288 [TBL] [Abstract][Full Text] [Related]
14. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. Hofmann SC; Saborowski V; Lange S; Kern WV; Bruckner-Tuderman L; Rieg S J Am Acad Dermatol; 2012 Jun; 66(6):966-74. PubMed ID: 21982063 [TBL] [Abstract][Full Text] [Related]
15. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Scheinfeld N Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361 [TBL] [Abstract][Full Text] [Related]
16. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo. Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036 [TBL] [Abstract][Full Text] [Related]
17. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa. Campanati A; Orciani M; Sorgentoni G; Consales V; Offidani A; Di Primio R JAMA Dermatol; 2018 Oct; 154(10):1184-1190. PubMed ID: 30140888 [TBL] [Abstract][Full Text] [Related]
18. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa. Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338 [TBL] [Abstract][Full Text] [Related]
19. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. Leslie KS; Tripathi SV; Nguyen TV; Pauli M; Rosenblum MD J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876 [TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Brocard A; Knol AC; Khammari A; Dréno B Dermatology; 2007; 214(4):325-7. PubMed ID: 17460404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]